Joseph M. Casper - 27 Jan 2026 Form 3 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
Chief Operating Officer
Signature
/s/ Joseph M. Casper
Issuer symbol
NRXP
Transactions as of
27 Jan 2026
Net transactions value
$0
Form type
3
Filing time
17 Feb 2026, 19:00:15 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Casper Joseph Michael Chief Operating Officer C/O NRX PHARMACEUTICALS, INC., 1201 ORANGE STREET, SUITE 600, WILMINGTON /s/ Joseph M. Casper 17 Feb 2026 0002106955

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NRXP Stock Options (Right to buy) 27 Jan 2026 Common Stock 100,000 $2.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 33.3% of the stock options shall vest on June 1, 2026, 33.3% shall vest on December 1, 2026, and the remaining 33.3% shall vest on December 1, 2027.